Nanjing Norman Biological Technology Co., Ltd
|
Payment Terms: | T/T,L/C,D/A,D/P,WU,Paypal,Money Gram |
Place of Origin: | Jiangsu, China (Mainland) |
Add to My Favorites | |
HiSupplier Escrow |
chemiluminescence immunoassay
Lp-PLA2 rapid test kits
Product Name
Lp-PLA2
Specific markers of cardiovascular inflammation,evaluating indicatorofatheromatous plaque
stability, independent risk factor for cardiovascular events,assist to guide clinical treatment
for cardiovascular patients.
Product Size
Quantity:50 pcs /box or 100 pcs/box
Size:11cm x 6cm x 8cm
Clinical Background
Coronary artery disease is associated with the severity of atherosclerosis, which is an
inflammatory disease.
But although helpful for guiding treatment and improving prognosis, standard
approaches for assessing a person's risk do not include inflammatory markers.
1.So, individuals with a moderate risk, as determined by standard approaches,
may actually be at greater risk of a myocardial infarction or stroke than predicted.
2. High-sensitivity C-reactive protein (hs-CRP) is a marker of systemic inflammation
that can improve risk stratification; however, it is not specific for cardiovascular disease.
On the other hand, lipoprotein-associated phospholipase A2 (Lp-PLA2) is a specific
marker of vascular inflammation associated with atherosclerosis.
3.Following production by inflammatory cells, this enzyme cleaves oxidized
phospholipids, generating pro-inflammatory molecules and oxidized fatty acids.
Individuals Suitable for Testing
1.Individuals with moderate risk of cardiovascular disease (≥2 risk factors and
Framingham 10-year risk score ≤20%);
2.Individuals with high risk of cardiovascular disease (Framingham 10-year risk
score >20%)
Individuals with coronary artery disease or risk equivalents (ie, symptomatic
carotid artery disease, peripheral artery disease, abdominal aortic aneurysm,
diabetes mellitus);
3.Individuals with moderate risk of stroke.
Applicable Department
Neurology, cardiology, endocrinology, Geriatrics, Department of physical examination;
Small necrotic lipid pool, thick fiber cap, high collagen, low Lp-pla2 content (dark stain),
vascular cavity, benign plaque, light inflammation;
big necrotic lipid pool, thin fiber cap, low collagen, high lp-pla2 content (dark stain),
vascular cavity, thrombus,Malignant plaque,severeinflammation;
A2 has better vascular inflammation specificity compare with hs-CRP and LDL.
Product Show
Package & Delivery
About Us
Company Profile
Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing
of automated chemiluminescence system. Founded in 2008, Norman biological has been
upholding the idea that R&D shapes future ,and concentration determines success.
Ever since the beginning, Norman has been focusing on developing and manufacturing
chemiluminescence instruments and reagents.
Norman's manufacture center is located in the Yuhua District and owns an
over 2,000m2 GMP-approved clean workshop. The R&D base, which is over 2,000m2,
is located in state-level new Jiangbei district. Now there are over 100 R&D engineers,
40% of which hold a PhD or master's degree.
Being an expert in automated chemiluminescence analysis , Norman owns independent
and completed intellectual property rights, and its products provide top-notch
sensitivity, precision and accuracy . Thanks to the self-developed
antigens and self-manufactured antibodies, Norman's products features minimized
intra-and inter- batch difference.
After 8 years development, Norman is now on the fast track. An over 30,000m2 global
R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.
Norman News
In order to promote international technology transfer and cooperation, strengthen the effective
docking between high-tech enterprises and the British innovation resources , facilitate
more overseas advanced technology which meet the needs of development of local
industry to land in Nanjing and realize industrialization, In the afternoon of March 23 ,
the leaders of high-tech district and British general consul stationed in Shanghai led
foreign entrepreneurs to visit Norman, president of Norman and other leadership
provided the visitors warm reception.
Foreign entrepreneurs delegation first visited our office management area, knew about
Norman core organization structure and function. Subsequently the delegation went to
R&D center for exchanging. Responsible person of R & D Center introduced the
development process of our products in detail to the members of the delegation.
Norman adheres to the independent research and development production of antigen
and antibody, this attitude let delegation feel deeply Norman's strong R & D strength
and spirit of rigorous attention. The delegation carefully inquired every items and
platform, The PCT items contained in chemiluminescence platform, is peripheral
blood detection, high accuracy, small volume, impressed the delegation and coursed
them to get great interest.
Related Products
Agent Wanted
We want to find partners, with whom we can work together stably in long term.
As a factory, we can offer support in both price and technical service.
If you are interested in working with us, please feel free to contact. We are eager
to work with you winning a bright future.
OEM will be highly welcome!
Welcome to our website!